Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study. (17th November 2017)

• Record Type: Journal Article
• Authors: Myhre, Peder Langeland; Stridsberg, Mats; Linko, Rita; Okkonen, Marjatta; Nygård, Ståle; Christensen, Geir; Pettilä, Ville; Omland, Torbjørn; Røsjø, Helge
• Is Part Of: Biomarkers. Volume 22:Number 8(2017)
• Page Start: 775
• Page End: 781
• Publication Date: 2017-11-17
• Subjects: Chromogranin B -- acute respiratory failure -- prognosis -- biomarker; Biochemical markers -- Periodicals; 610.28
• DOI: 10.1080/1354750X.2016.1269200
• Languages: English
• ISSNs: 1354-750X

Abstract

Abstract: Purpose: Circulating chromogranin B (CgB) levels are increased in situations characterized by systemic and myocardial stress, but whether CgB provides prognostic information in patients with acute respiratory failure (ARF) is unknown. Methods: We included 584 patients with ARF, defined as ventilatory support >6 h, and with blood samples available on Intensive Care Unit (ICU) admission and day 3 ( n = 479). CgB levels were measured by radioimmunoassay and follow-up was 90 days. Results: One-hundred-sixty-nine patients (29%) died during follow-up. Admission CgB levels separated non-survivors from survivors: median 1234 (Q1-3 989–1742) vs. 917 (753–1224) pmol/L, respectively, p < 0.001. CgB levels on ICU admission (logarithmically transformed) were associated with time to death after adjustment for established risk indices available on ICU admission, including N-terminal pro-B-type natriuretic levels: HR 2.62 (95%C.I. 1.82–3.77), p < 0.001. Admission CgB levels also improved prognostication on top of SOFA and SAPS II scores as assessed by Cox regression analyses and the category-free net reclassification index. The area under the curve (AUC) for admission CgB levels to separate survivors and non-survivors was 0.72 (95%CI 0.67–0.76), while the AUC on day 3 was 0.60 (0.54–0.66). Conclusions: CgB levels measured on ICU admission provided additional prognostic information to established risk indices in ARF patients.